Anna Wojcicka Mitchell, MD
Neurology · Joplin, MONPI 1851594477
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 6 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Genentech, Inc. accounts for 61.2% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2024 at $120 and has fallen 72.0% since, to $34 in 2025. That places this record below the midpoint for neurology clinicians in MO, where the typical reported total is $933.
Across 6 payments — averaging $32.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$120
- Amneal Pharmaceuticals LLC$17
- Axsome Therapeutics, Inc.$16
- Argenx US, Inc.$16
- AbbVie$14
- Ceribell, Inc.$13
What the payments were for
- Food & beverage$196100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 1 | $120 |
| Amneal Pharmaceuticals LLC | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Argenx US, Inc. | 1 | $16 |
| AbbVie | 1 | $14 |
| Ceribell, Inc. | 1 | $13 |
How this compares
$196 in reported general payments places this provider in the 30th percentile of 381 neurology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Kesimpta PenOfatumumab | 21 | $226,604 |
| CopaxoneGlatiramer Acetate | 25 | $178,060 |
| VumerityDiroximel Fumarate | 15 | $150,452 |
| Austedo XrDeutetrabenazine | 13 | $93,276 |
| QuliptaAtogepant | 77 | $93,087 |
| Aimovig AutoinjectorErenumab-Aooe | 79 | $68,397 |
| Dimethyl Fumarate | 18 | $68,082 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 785 | $25,206 |
| Lacosamide | 219 | $22,430 |
| Ajovy AutoinjectorFremanezumab-Vfrm | 27 | $21,688 |
| Emgality PenGalcanezumab-Gnlm | 19 | $13,645 |
| Nurtec OdtRimegepant Sulfate | 12 | $12,932 |
| Entacapone | 70 | $12,059 |
| Pregabalin | 347 | $8,025 |
| Levetiracetam | 239 | $7,642 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieQulipta | $14 | $93,08777 claims |
| Amneal Pharmaceuticals LLCPyridostigmine Bromide | $17 | $4,37471 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 381 neurology providers in Missouri.
Other neurology in Joplin
- Gulshan UppalJoplin$200K
- Christopher AndrewJoplin$77K
- William RosenfeldChesterfield$2.1M
- Barry SingerSaint Louis$1.9M
- Mark TullmanSaint Louis$1.5M
- Curtis SchreiberBolivar$882K
- Robert NaismithSaint Louis$677K
- Daniel MattsonBridgeton$451K
- Siddharth KaulBridgeton$387K
- Barbara GreenChesterfield$352K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.